We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Open Drawer MenuClose Drawer Menu
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Editorial

Uncovering cancer’s secrets: could liquid biopsies and artificial intelligence hold the answers?

    Published Online:15 Jun 2023https://doi.org/10.2217/fon-2023-0428

    Abstract

    Tweetable abstract

    How are #liquidbiopsies and #AI pushing us closer to the goal of early cancer detection for all? Plus, what more needs to be done to truly deciphers cancer's secrets? Find out in this editorial by @JadeParkerB

    References

    • 1. Parker J. How has CRISPR transformed therapeutic drug discovery? BioTechniques 74(3), 119–121 (2023)
      Medline CASGoogle Scholar
    • 2. Behan FM, Iorio F, Picco G et al. Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. Nature 568(7753), 511–516 (2019)
      Medline CASGoogle Scholar
    • 3. Dwane L, Behan FM, Gonçalves E et al. Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets. Nucleic Acids Res. 49(D1), D1365–D1372 (2021)
      Medline CASGoogle Scholar
    • 4. Cancer Cell Encyclopedia. Accessed May 2023. https://sites.broadinstitute.org/ccle/
      Google Scholar
    • 5. ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306(5696), 636–640 (2004)
      MedlineGoogle Scholar
    • 6. Liu MC, Oxnard GR, Klein EA et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 31(6), 745–759 (2020)
      Medline CASGoogle Scholar
    • 7. Connal S, Cameron JM, Sala A et al. Liquid biopsies: the future of cancer early detection. J. Transl. Med. 21(1), 118 (2023)
      MedlineGoogle Scholar
    • 8. Vaccarella S, Franceschi S, Bray F et al. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N. Engl. J. Med. 375(7), 614 (2016)
      MedlineGoogle Scholar
    • 9. Tessler FN, Middleton WD, Grant EG et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS Committee. J. Am. Coll. Radiol. 14(5), 587–595 (2017)
      MedlineGoogle Scholar
    • 10. Mikhael PG, Wohlwend J, Yala A et al. Sybil: a validated deep learning model to predict future lung cancer risk from a single low-dose chest computed tomography. J Clin Oncol. 41(12), 2191–2200 (2023)
      MedlineGoogle Scholar
    • 11. Hunter B, Chen M, Ratnakumar P et al. A radiomics-based decision support tool improves lung cancer diagnosis in combination with the Herder score in large lung nodules. eBioMedicine. doi: 10.1016/j.ebiom.2022.104344 (2010). (ePub ahead of print)
      Google Scholar
    • 12. Holmström O, Linder N, Kaingu H et al. Point-of-care digital cytology with artificial intelligence for cervical cancer screening in a resource-limited setting. JAMA Netw. Open. 4(3), e211740 (2021)
      MedlineGoogle Scholar
    • 13. Lu MY, Chen TY, Williamson DFK et al. AI-based pathology predicts origins for cancers of unknown primary. Nature. 594(7861), 106–110 (2021)
      Medline CASGoogle Scholar
    • 14. Lone SN, , al. (21)79 (2022)., Nisar S, Masoodi Tet et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol. Cancer. 21(79), (2022).
      MedlineGoogle Scholar